|
|
Volumn 3, Issue 5, 2001, Pages 417-
|
|
Combination therapy in hormone-refractory prostate cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
ANTINEOPLASTIC AGENT;
DOCETAXEL;
DRUG DERIVATIVE;
ESTRAMUSTINE;
HYDROCORTISONE;
PACLITAXEL;
TAXOID;
EDITORIAL;
HUMAN;
MALE;
PHASE 2 CLINICAL TRIAL;
PROSTATE TUMOR;
ANTI-INFLAMMATORY AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS, PHASE II;
ESTRAMUSTINE;
HUMANS;
HYDROCORTISONE;
MALE;
PACLITAXEL;
PROSTATIC NEOPLASMS;
TAXOIDS;
|
|
EID: 0035462334
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-001-0033-4 Document Type: Editorial |
|
Times cited : (3)
|
|
References (0)
|
